Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of Pitavastatin on Insulin Sensitivity and Liver Fat

Next Previous
Trial Profile

Effects of Pitavastatin on Insulin Sensitivity and Liver Fat

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pitavastatin (Primary)
  • Indications Obesity
  • Focus Therapeutic Use

Most Recent Events

  • 20 Apr 2020 Results published in the Journal of Infectious Diseases
  • 17 Sep 2018 Primary endpoint (Liver fat) has not been met, according to the results published in the Journal of Clinical Endocrinology and Metabolism
  • 17 Sep 2018 Primary endpoint (Insulin-stimulated glucose uptake) has not been met, according to the results published in the Journal of Clinical Endocrinology and Metabolism

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top